On the public citation graph

https://doi.org/10.2139/ssrn.4622835

0 signed · 20 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/0471220639openalex-extracted
Enzymes
inferredcites →https://doi.org/10.1002/emmm.201303575openalex-extracted
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
inferredcites →https://doi.org/10.1002/rcm.2265openalex-extracted
Rapid and direct measurement of free concentrations of highly protein‐bound fluoxetine and its metabolite norfluoxetine in plasma
inferredcites →https://doi.org/10.1016/j.ejmech.2014.08.061openalex-extracted
Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents
inferredcites →https://doi.org/10.1016/j.ejmech.2018.03.060openalex-extracted
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety
inferredcites →https://doi.org/10.1016/j.ejmech.2020.112773openalex-extracted
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents
inferredcites →https://doi.org/10.1016/j.trsl.2020.03.007openalex-extracted
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01215openalex-extracted
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c00098openalex-extracted
Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones
inferredcites →https://doi.org/10.1021/acs.jmedchem.8b00281openalex-extracted
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis
inferredcites →https://doi.org/10.1021/acsmedchemlett.1c00652openalex-extracted
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents
inferredcites →https://doi.org/10.1021/acsmedchemlett.8b00634openalex-extracted
Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties
inferredcites →https://doi.org/10.1021/cb5007163openalex-extracted
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
inferredcites →https://doi.org/10.1021/jm3008882openalex-extracted
Identification of Antitubercular Benzothiazinone Compounds by Ligand-Based Design
inferredcites →https://doi.org/10.1021/ml5003458openalex-extracted
Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043
inferredcites →https://doi.org/10.1038/s41598-018-31316-6openalex-extracted
Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
inferredcites →https://doi.org/10.1111/j.1365-2125.2011.04076.xopenalex-extracted
Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes
inferredcites →https://doi.org/10.1126/science.1171583openalex-extracted
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
inferredcites →https://doi.org/10.1128/aac.00681-18openalex-extracted
Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
inferredcites →https://doi.org/10.2139/ssrn.4276522openalex-extracted
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.